Washington, DC– According to state and local economic development sources Bristol Myers Squibb plans to invest $1,045,900.00 to build out 5,879 square feet of new space in Washington. The company plans to occupy the new space at 801 Pennsylvania Ave NW 7th Fl in Washington, on or about July 1, 2021. According to the company website At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation. We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. We aspire to be at the center of a vibrant healthcare innovation ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.

To learn more about Bristol Myers Squibb, visit http://www.bms.com/

Company Contact:
Giovanni Caforio, Chief Executive Officer
giovanni.caforio@bms.com
https://www.linkedin.com/in/giovanni-caforio-b826864/
800-332-2056

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved